- Home
- BYRN vs CTKB Comparison
BYRN vs CTKB Comparison
Compare BYRN & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BYRN
- CTKB
- Stock Information
- Founded
- BYRN 2005
- CTKB 1990
- Country
- BYRN United States
- CTKB United States
- Employees
- BYRN N/A
- CTKB N/A
- Industry
- BYRN Industrial Machinery/Components
- CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BYRN Miscellaneous
- CTKB Health Care
- Exchange
- BYRN Nasdaq
- CTKB Nasdaq
- Market Cap
- BYRN 485.6M
- CTKB 526.7M
- IPO Year
- BYRN N/A
- CTKB 2021
- Fundamental
- Price
- BYRN $20.03
- CTKB $4.13
- Analyst Decision
- BYRN Strong Buy
- CTKB Hold
- Analyst Count
- BYRN 2
- CTKB 4
- Target Price
- BYRN $41.50
- CTKB $6.00
- AVG Volume (30 Days)
- BYRN 486.0K
- CTKB 1.0M
- Earning Date
- BYRN 10-08-2025
- CTKB 11-04-2025
- Dividend Yield
- BYRN N/A
- CTKB N/A
- EPS Growth
- BYRN N/A
- CTKB N/A
- EPS
- BYRN 0.62
- CTKB N/A
- Revenue
- BYRN $103,528,000.00
- CTKB $196,035,000.00
- Revenue This Year
- BYRN $38.01
- CTKB $0.09
- Revenue Next Year
- BYRN $21.31
- CTKB $7.45
- P/E Ratio
- BYRN $31.51
- CTKB N/A
- Revenue Growth
- BYRN 73.56
- CTKB N/A
- 52 Week Low
- BYRN $13.10
- CTKB $2.37
- 52 Week High
- BYRN $34.78
- CTKB $7.63
- Technical
- Relative Strength Index (RSI)
- BYRN 44.64
- CTKB 57.98
- Support Level
- BYRN $18.90
- CTKB $3.85
- Resistance Level
- BYRN $22.00
- CTKB $4.23
- Average True Range (ATR)
- BYRN 1.29
- CTKB 0.16
- MACD
- BYRN 0.18
- CTKB -0.03
- Stochastic Oscillator
- BYRN 39.94
- CTKB 65.12
About BYRN Byrna Technologies Inc.
Byrna Technologies Inc is a designer, manufacturer, retailer, and distributor of technological solutions for security situations that do not require the use of lethal force. The company generates its revenue from the United States, South Africa, Europe, South America, Asia, and Canada.
About CTKB Cytek Biosciences Inc.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.